1.
Al-Rawashde FA, Alqaraleh M, Alhmoud JF, Al-Sanabra OM, Saad HKM, Odat N, et al. In silico Evaluation of the Antileukemia Activities of Thymoquinone by Targeting FLT3-ITD and BCR-ABL Signaling in Myeloid leukemia. TJNPR [Internet]. 2024 Jun. 29 [cited 2024 Dec. 22];8(6):7447-51. Available from: https://tjnpr.org/index.php/home/article/view/4200